Victory Pharma acquisition to boost Shionogi's pain ambitions
This article was originally published in Scrip
Executive Summary
The Shionogi group company Sciele Pharma is to acquire the private US firm Victory Pharma for $150 million to expand its presence in the pain management area. The deal is expected to close in the second quarter, subject to antitrust and other clearances.